KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Interest & Investment Income: 2017-2024

Historic Interest & Investment Income for Adaptive Biotechnologies (ADPT) over the last 8 years, with Dec 2024 value amounting to $14.5 million.

  • Adaptive Biotechnologies' Interest & Investment Income fell 35.92% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 35.50%. This contributed to the annual value of $14.5 million for FY2024, which is 6.42% down from last year.
  • As of FY2024, Adaptive Biotechnologies' Interest & Investment Income stood at $14.5 million, which was down 6.42% from $15.5 million recorded in FY2023.
  • Over the past 5 years, Adaptive Biotechnologies' Interest & Investment Income peaked at $15.5 million during FY2023, and registered a low of $1.7 million during FY2021.
  • For the 3-year period, Adaptive Biotechnologies' Interest & Investment Income averaged around $11.4 million, with its median value being $14.5 million (2024).
  • Per our database at Business Quant, Adaptive Biotechnologies' Interest & Investment Income slumped by 74.69% in 2021 and then soared by 282.91% in 2023.
  • Yearly analysis of 5 years shows Adaptive Biotechnologies' Interest & Investment Income stood at $6.6 million in 2020, then slumped by 74.69% to $1.7 million in 2021, then surged by 143.17% to $4.1 million in 2022, then soared by 282.91% to $15.5 million in 2023, then decreased by 6.42% to $14.5 million in 2024.